- KASL clinical practice guidelines: management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363029
- Clin Mol Hepatol.
- 2016 Mar;22(1):18-75.
- doi: 10.3350/cmh.2016.22.1.18
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Monitoring Patients with Chronic HBV Infection During Antiviral Therapy
-
Kim YS
- KMID: 760572
- Korean J Hepatol.
- 2005 Mar;11(1):9-12.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection
-
Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
- KMID: 1073303
- Korean J Hepatol.
- 2008 Dec;14(4):513-518.
- doi: 10.3350/kjhep.2008.14.4.513
The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naive Patients with HBeAg Positive Chronic Hepatitis B
-
Kim IH, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Choi CS, Kim HC
- KMID: 1713959
- J Korean Med Sci.
- 2010 May;25(5):738-745.
- doi: 10.3346/jkms.2010.25.5.738
The authors assessed the efficacy and antiviral resistance of 48-week clevudine therapy versus lamivudine in treatment of naive patients with HBeAg positive chronic hepatitis B. In this retrospective study, a... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Lamivudine Re-treatment and Relapse Patterns after Initial Lamivudine Treatment for Chronic Hepatitis B Infection
-
Park JH, Park NH, Shin JW, Bang SJ, Kim DH, Joo KR, Kim DH
- KMID: 863154
- Korean J Hepatol.
- 2003 Sep;9(3):188-197.
BACKGROUND/AIMS: The post-treatment relapse patterns and efficacy of lamivudine re-treatment for relapsed patients have not been clarified. The aims of this study were to evaluate the relapse patterns after discontinuing... -
- CITED
-
- Close
- SHARE
-
- Close
- Pretreatment ALT Level and Histologic Activity as Predictors of HBeAg Loss in Lamivudine Treatment for Chronic Hepatitis B
-
Kweon YO, Kang KH
- KMID: 760529
- Korean J Hepatol.
- 2004 Mar;10(1):31-41.
BACKGROUND/AIMS: Lamivudine is a potent inhibitor of hepatitis B virus replication, but an increased incidence of YMDD mutation may be associated with its long term use. Thus, the decision... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT
-
Han DH, Park NH, Shin JW, Jung SW, Hwang YT, Kim HS, Jeong ID, Bang SJ, Kim DH
- KMID: 760718
- Korean J Hepatol.
- 2007 Jun;13(2):146-156.
BACKGROUND/AIMS: The aim of this study was to compare the efficacy of lamivudine therapy between chronic hepatitis B (CHB) patients, whose ALT levels less than 2 times the upper... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
-
Jo YJ, Kim KA, Lee JS, Kim NH, Bae WK, Song TJ, Kim JW
- KMID: 2160681
- Korean J Intern Med.
- 2015 Mar;30(2):170-176.
- doi: 10.3904/kjim.2015.30.2.170
BACKGROUND/AIMS: The clinical outcome of patients with a partial virological response (PVR) to entecavir (ETV), in particular nucloes(t)ide analogue (NA)-experienced patients, has not been thoroughly investigated. The aim of the... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection
-
Moon JH, Cho M, Yoon KT, Bae JH, Heo J, Kim GH, Kang DH, Song GA
- KMID: 1073302
- Korean J Hepatol.
- 2008 Dec;14(4):503-512.
- doi: 10.3350/kjhep.2008.14.4.503
BACKGROUND/AIMS: Adefovir dipivoxil (ADV) is a nucleotide analogue that inhibits wild-type hepatitis B virus (HBV) and lamivudine (LMV)-resistant HBV mutants. The aim of this study was to elucidate the... -
- CITED
-
- Close
- SHARE
-
- Close
